SERAFINI, MARTA
 Distribuzione geografica
Continente #
NA - Nord America 4.691
AS - Asia 4.121
EU - Europa 2.846
SA - Sud America 620
AF - Africa 89
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 4
Totale 12.379
Nazione #
US - Stati Uniti d'America 4.546
SG - Singapore 1.427
CN - Cina 855
IT - Italia 851
VN - Vietnam 700
HK - Hong Kong 538
RU - Federazione Russa 531
BR - Brasile 524
DE - Germania 344
IE - Irlanda 280
SE - Svezia 253
GB - Regno Unito 135
ID - Indonesia 120
KR - Corea 99
CA - Canada 98
IN - India 98
FI - Finlandia 80
UA - Ucraina 73
FR - Francia 63
JP - Giappone 48
TR - Turchia 48
AR - Argentina 45
ZA - Sudafrica 42
BD - Bangladesh 40
NL - Olanda 38
ES - Italia 37
MX - Messico 35
PL - Polonia 35
PK - Pakistan 29
AT - Austria 27
BE - Belgio 24
IR - Iran 21
IQ - Iraq 18
CH - Svizzera 13
DK - Danimarca 13
EC - Ecuador 13
CO - Colombia 12
EG - Egitto 12
MA - Marocco 12
RO - Romania 9
SA - Arabia Saudita 9
IL - Israele 8
LT - Lituania 8
NO - Norvegia 8
TW - Taiwan 8
AE - Emirati Arabi Uniti 7
AU - Australia 7
CL - Cile 7
CZ - Repubblica Ceca 7
PY - Paraguay 7
UZ - Uzbekistan 6
ET - Etiopia 5
KE - Kenya 5
KZ - Kazakistan 5
LB - Libano 5
JO - Giordania 4
MY - Malesia 4
NP - Nepal 4
PE - Perù 4
PH - Filippine 4
TN - Tunisia 4
VE - Venezuela 4
AL - Albania 3
AZ - Azerbaigian 3
BH - Bahrain 3
CI - Costa d'Avorio 3
KG - Kirghizistan 3
SK - Slovacchia (Repubblica Slovacca) 3
AM - Armenia 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
HN - Honduras 2
HR - Croazia 2
JM - Giamaica 2
LA - Repubblica Popolare Democratica del Laos 2
LV - Lettonia 2
NI - Nicaragua 2
PA - Panama 2
RS - Serbia 2
TH - Thailandia 2
UY - Uruguay 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BO - Bolivia 1
CR - Costa Rica 1
EE - Estonia 1
EU - Europa 1
GA - Gabon 1
GR - Grecia 1
GT - Guatemala 1
GY - Guiana 1
HU - Ungheria 1
KH - Cambogia 1
NZ - Nuova Zelanda 1
SN - Senegal 1
UG - Uganda 1
Totale 12.379
Città #
Singapore 862
Ann Arbor 820
Hong Kong 533
Ashburn 516
Dublin 275
Chandler 268
Milan 241
Ho Chi Minh City 236
Hefei 208
Fairfield 186
Houston 184
Frankfurt am Main 166
Wilmington 166
Hanoi 159
New York 146
Los Angeles 144
Beijing 128
Santa Clara 123
Dallas 111
Jakarta 103
Woodbridge 99
Seoul 93
Seattle 91
Dearborn 76
São Paulo 67
Jacksonville 63
Princeton 61
Shanghai 60
Cambridge 57
Buffalo 56
Chicago 49
The Dalles 46
Moscow 43
Munich 41
Bergamo 40
Tokyo 40
Denver 38
Nanjing 32
Johannesburg 31
Helsinki 29
Turin 28
Haiphong 27
Montreal 27
Warsaw 27
Lawrence 26
Nuremberg 26
Rome 25
Monza 24
Orem 24
Council Bluffs 23
London 22
Altamura 20
Lappeenranta 20
Chennai 19
Guangzhou 19
Toronto 19
Brussels 18
Lissone 18
San Diego 18
Stockholm 18
Hải Dương 17
Phoenix 17
Turku 17
Atlanta 16
Brooklyn 16
Rio de Janeiro 16
Bologna 15
Ankara 14
Biên Hòa 14
Borgomanero 14
Mumbai 14
Ottawa 14
Poplar 14
Vienna 14
Belo Horizonte 13
Bắc Ninh 13
Ha Long 13
Mexico City 13
Brasília 12
Carate Brianza 12
Carrboro 12
Da Nang 12
Jinan 12
Lahore 12
Boardman 11
Can Tho 11
Contursi 11
Kent 11
Kocaeli 11
Lachine 11
Quận Bình Thạnh 11
Tianjin 11
Amsterdam 10
Baghdad 10
Desio 10
Hyderabad 10
Querétaro 10
Salt Lake City 10
San Jose 10
Sesto San Giovanni 10
Totale 7.639
Nome #
Acute myeloid leukaemia niche regulates response to L-asparaginase 406
Zoledronic Acid in a Mouse Model of Human Fibrous Dysplasia: Ineffectiveness on Tissue Pathology, Formation of “Giant Osteoclasts” and Pathogenetic Implications 367
Targeting CD33 in Chemoresistant AML Patient-Derived Xenografts by CAR-CIK Cells Modified with an Improved SB Transposon System 356
Fludarabine as a cost-effective adjuvant to enhance engraftment of human normal and malignant hematopoiesis in immunodeficient mice 324
First-hit SETBP1 mutations cause a myeloproliferative disorder with bone marrow fibrosis 309
Acute myeloid leukemia shapes the bone marrow stromal niche in vivo 298
Human umbilical cord blood-borne fibroblasts contain marrow niche precursors that form a bone/marrow organoid in vivo 297
Transposon-Based CAR T Cells in Acute Leukemias: Where are We Going? 296
Location First: Targeting Acute Myeloid Leukemia Within Its Niche 289
Human aplastic anaemia-derived mesenchymal stromal cells form functional haematopoietic stem cell niche in vivo 285
CXCR4-MODIFIED CD33.CAR-CIK WITH ENHANCED BONE MARROW HOMING IN ACUTE MYELOID LEUKEMIA 279
Neonatal combination therapy improves some of the clinical manifestations in the Mucopolysaccharidosis type I murine model 271
Characterization of Plated Lysate Cultured Mesenchymal Stromal Cells and Their Potential Use in Tissue-Engineered Osteogenic Devices for the Treatment of Bone Defects 266
Expanded circulating hematopoietic stem/progenitor cells as novel cell source for the treatment of TCIRG1 osteopetrosis 246
Neonatal umbilical cord blood transplantation halts skeletal disease progression in the murine model of MPS-I 239
Selective homing of CAR-CIK cells to the bone marrow niche enhances control of the Acute Myeloid Leukemia burden 236
Mesenchymal stem cells from Shwachman-Diamond syndrome patients display normal functions and do not contribute to hematological defects 233
Characterization of CD20-transduced T lymphocytes as an alternative suicide gene therapy approach for the treatment of graft-versus-host disease 230
Catch me if you can: how AML and its niche escape immunotherapy 224
Safe and effective off-the-shelf immunotherapy based on CAR.CD123-NK cells for the treatment of acute myeloid leukaemia 221
Overexpression of CXCR4 receptor on CD33.CAR-CIK cells enhances the control of the Acute Myeloid Leukemia burden 211
Neonatal bone marrow transplantation prevents bone pathology in a mouse model of mucopolysaccharidosis type I 210
Heterogeneity of the bone marrow niche in patients with myeloproliferative neoplasms: ActivinA secretion by mesenchymal stromal cells correlates with the degree of marrow fibrosis 210
Functional transfer of CD40L gene in human B-cell precursor ALL blasts by second-generation SIN lentivectors 206
Cellule CD33.CAR-CIK ingegnerizzate per co-esprimere il recettore CXCR4 al fine di aumentare la capacità di migrazione all’interno della nicchia midollare nella leucemia mieloide acuta 204
Combining the Expression of CD33.CAR and CXCR4 to Increase CAR-CIK Cell Homing to Bone Marrow Niche and Leukemic Stem Cell Eradication in Acute Myeloid Leukemia 202
Comparative analysis of multilineage properties of mesenchymal stromal cells derived from fetal sources shows an advantage of mesenchymal stromal cells isolated from cord blood in chondrogenic differentiation potential 196
Overexpression of CXCR4 Enhances the Efficacy of CAR-T Therapy for Acute Myeloid Leukemia 194
Combining the expression of CD33.CAR and CXCR4 to augment CAR-CIKs homing to bone marrow niche and leukemic stem cell eradication in acute myeloid leukemia 188
Hurler disease bone marrow stromal cells exhibit altered ability to support osteoclast formation 186
IL3-zetakine combined with a CD33 costimulatory receptor as a Dual CAR approach for safer and selective targeting of AML 184
Detailed investigation of obstetric factors influencing isolation efficiency of fetal mesenchymal stem cells (FMSCS) from amniotic fluid and cord blood samples 180
Isolation of single circulating trophoblasts from maternal circulation for noninvasive fetal copy number variant profiling 179
Neonatal cellular and gene therapies for mucopolysaccharidoses: the earlier the better? 179
Engineering tandem CD33xCD146 CAR CIK (cytokine-induced killer) cells to target the acute myeloid leukemia niche 177
Optimized GMP-grade production of non-viral Sleeping Beauty-generated CARCIK cells for enhanced fitness and clinical scalability 175
Generation of CIK cells co-expressing CXCR4 and CD33.CAR with improved homing and antitumor activity for AML 173
Establishment of bone marrow and hematopoietic niches in vivo by reversion of chondrocyte differentiation of human bone marrow stromal cells 172
CARs are sharpening their weapons 166
Improving Bone Marrow Homing and Persistence of CD33.CAR-CIK Cells By Overexpression of a Gain-of-Function Variant of CXCR4 to Increase Efficacy in Acute Myeloid Leukemia 164
Bone marrow mesenchymal stromal cells support translation in refractory acute myeloid leukemia 155
Exonic knockout and knockin gene editing in hematopoietic stem and progenitor cells rescues RAG1 immunodeficiency 150
First-Hit SETBP1 Mutations Cause a Myeloproliferative Disorder with Bone Marrow Fibrosis 149
Elongation factor 1 (EF1α) promoter in a lentiviral backbone improves expression of the CD20 suicide gene in primary T lymphocytes allowing efficient rituximab-mediated lysis 149
First-Hit SETBP1 Mutations Cause a Myeloproliferative Disorder with Bone Marrow Fibrosis Mimicking Triple Negative Myelofibrosis 147
AML alters bone marrow stromal cell osteogenic commitment via Notch signaling 144
An in vivo humanized model to study homing and sequestration of Plasmodium falciparum transmission stages in the bone marrow. 142
Modeling skeletal dysplasia in Hurler syndrome using patient-derived bone marrow osteoprogenitor cells 141
Ingegnerizzazione di cellule CD33.CAR-CIK con una variante gain-of-function del recettore CXCR4 per aumentarne migrazione e persistenza nella nicchia midollare 140
Fully equipped CARs to address tumor heterogeneity, enhance safety, and improve the functionality of cellular immunotherapies 138
A Question of Frame: The Role of the Bone Marrow Stromal Niche in Myeloid Malignancies 129
Bone marrow mesenchymal stromal cells induce nitric oxide synthase-dependent differentiation of CD11b+ cells that expedite hematopoietic recovery 129
CD14 positive cells accelerate hematopoietic stem cell engraftment 125
Acute Myeloid Leukemia (AML) immunotherapy: development of TIM3-CD33 targeted Dual CAR CIK cells for eradication of LSCs in the bone marrow niche 124
Defective IL-10-mediated modulation of monocytes from autoimmune patients 105
MPSI Manifestations and Treatment Outcome: Skeletal Focus 91
Effect of Aplidin in acute lymphoblastic leukaemia cells 87
mTORC1 hyperactivation arrests bone growth in lysosomal storage disorders by suppressing autophagy 86
GsαR201C and estrogen reveal different subsets of bone marrow adiponectin expressing osteogenic cells 83
Morphological and immunophenotypical changes of human bone marrow adipocytes in marrow metastasis and myelofibrosis. 79
From stem cells to bone-forming cells 73
Human T cells engineered with a leukemia lipid-specific TCR enables donor-unrestricted recognition of CD1c-expressing leukemia 67
Intracellular free radical production by peripheral blood T lymphocytes from patients with systemic sclerosis: role of NADPH oxidase and ERK1/2 65
Solitary juvenile xanthogranuloma of the hypopharynx. Clinico-pathologic study in a child with β-Thalassemia Major and Cutaneous Mastocytosis 65
Harnessing Mesenchymal Stromal Cells for the Engineering of Human Hematopoietic Niches 62
Hematopoietic reconstitution by multipotent adult progenitor cells: Precursors to long-term hematopoietic stem cells 61
Hematopoietic Stem Cell Transplantation for Mucopolysaccharidoses: Past, Present, and Future 60
No identical "mesenchymal stem cells" at different times and sites: Human committed progenitors of distinct origin and differentiation potential are incorporated as adventitial cells in microvessels 58
Molecular evidence of inefficient transduction of proliferating human B lymphocytes by VSV-pseudotyped HIV-1-derived lentivectors 53
Gene Therapy for Mucopolysaccharidoses: In Vivo and Ex Vivo Approaches 53
Pluripotency in adult stem cells: State of the art 51
Lentiviral vectors show dramatically increased efficiency of transduction of human leukemic cell lines 50
A human immunodeficiency virus type 1 pol gene-derived sequence (cPPT/CTS) increases the efficiency of transduction of human nondividing monocytes and T lymphocytes by lentiviral vectors 50
Neonatal gene therapy effectively prevents disease manifestations in a murine model of Mucopolysaccharidosis type I 44
Totale 12.733
Categoria #
all - tutte 43.866
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.866


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021543 0 0 0 0 0 84 71 75 70 110 60 73
2021/2022624 63 61 63 54 44 50 25 19 34 43 42 126
2022/2023993 112 248 70 108 29 144 24 69 71 12 80 26
2023/20241.282 41 36 57 78 105 287 163 137 143 49 40 146
2024/20253.076 155 270 222 135 239 202 215 100 286 446 304 502
2025/20264.628 1.173 685 560 975 918 317 0 0 0 0 0 0
Totale 12.733